Jill C. Milne
Chief Executive Officer, Catabasis Pharmaceuticals.
Companies
- BioCryst PharmaceuticalsBoard member Jan 27, 2026 to now1
- Catabasis PharmaceuticalsBoard member Jun 24, 2015 to now2
- Catabasis PharmaceuticalsChief executive officer Jun 24, 2015 to now2
- Catabasis PharmaceuticalsPresident Jun 24, 2015 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioCryst Pharmaceuticals BCRX33,226 shares3$265.3K at $7.99Aug 31, 2026- Catabasis Pharmaceuticals CATB0 shares4Jan 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 31, 2026Granted 1,288 shares at $9.70 of BioCryst Pharmaceuticals3
- Jun 11, 2026Granted 15,294 shares of BioCryst Pharmaceuticals5
- May 29, 2026Granted 1,262 shares at $8.91 of BioCryst Pharmaceuticals6
- Feb 27, 2026Granted 528 shares at $8.75 of BioCryst Pharmaceuticals7
- Jan 23, 2026Granted 12,272 shares of BioCryst Pharmaceuticals8
- Jan 23, 2026Granted 2,582 shares of BioCryst Pharmaceuticals8
- Jan 23, 2026Returned to company 4,377 shares of Catabasis Pharmaceuticals4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 15, 2026
- 6SEC EDGARForm 4 filed Jun 2, 2026
- 7SEC EDGARForm 4 filed Mar 3, 2026
- 8SEC EDGARForm 4 filed Jan 27, 2026